ACIP Presentation Slides: November 2-3, 2021 Meeting

Note: These files are not yet 508

Slides will be added as they become available.

November 2, 2021

Welcome & Introductions

• Introduction
  Dr. G Lee
  Dr. M Wharton

Coronavirus Disease 2019 (COVID-19) Vaccines

• Introduction [9 pages]
  Dr. M Daley
• Pfizer-BNT162b2 use in children aged 5-11 years [31 pages]
  Dr. A Gurtman
• SARS-CoV-2 Epidemiology in children [29 pages]
  Dr. J Jones
• Myocarditis in adolescents and young adults [23 pages]
  Dr. M Oster
• Vaccine safety surveillance in children [25 pages]
  Dr. T Shimabukuro
• Implementation of COVID-19 vaccine pediatric program [10 pages]
  Dr. K Chatham-Stevens
• Clinical considerations for COVID-19 vaccination in children [33 pages]
  Dr. K Woodworth
• Evidence to Recommendations Framework: Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years [80 pages]
  Dr. S Oliver

November 3, 2021

Welcome & Introductions

• Introduction
  Dr. G Lee
  Dr. M Wharton

Hepatitis Vaccines

• Introduction [11pages]
  Dr. K Ault
  
• Considerations for a Universal Adult HepB Recommendation [24 pages]
  Dr. M Weng

Immunization Schedules

• Introduction to Combined Immunization Schedule Work Group; Proposed Changes to 2022 Child and Adolescent Schedule; Proposed Changes to 2022 Adult Schedule [145 pages]
  Dr. K Ault; Dr. P Wodi; Dr. A Hause

Orthopoxviruses Vaccines

• Introduction [7 pages]
  Dr. P Sanchez
• Clinical guidance for use of JYNNEOS [23 pages]
  Dr. B Petersen
• Summary of work group considerations and proposed policy options [110 pages]
  Dr. A Rao

Ebola Vaccine

• Introduction [10 pages]
  Dr. W Chen
• Review of State Designated Ebola Treatment Centers and Laboratory Response Network Facilities [48 pages]
  Dr. A Whitesell
• Evidence to Recommendations Framework [65 pages]
  Dr. J Malenfant
• Proposed Policy Questions [7 pages]
  Dr. C Cossaboom